Work

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-16-1918

Authors: Steven P. Treon, Kirsten Meid, Christina Tripsas, Leonard T. Heffner, Herbert Eradat, Ashraf Z. Badros, Lian Xu, Zachary R. Hunter, Guang Yang, Christopher J. Patterson, Joshua Gustine, Jorge J. Castillo, Jeffrey Matous, Irene M. Ghobrial

Institutions: Harvard University, Dana-Farber Cancer Institute, Emory University, Winship Cancer Institute, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of Maryland, Baltimore, Rocky Mountain Cancer Centers

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2549946323

FWCI: 2.584

Cites: 23

Cited by: 27

Related to: 10